dazodalibep   Click here for help

GtoPdb Ligand ID: 13453

Synonyms: MEDI-4920 | MEDI4920 | VIB 4920 | VIB-4920 | VIB4920
Immunopharmacology Ligand
Compound class: Peptide
Comment: Dazodalibep (VIB4920, formerly MEDI4920) is a fusion protein that is designed to bind to and neutralise the biological actions of the CD40 ligand (CD40L) [1-2]. Structurally dazodalibep contains two tandem human Tn3 tenascin C modules (that bind CD40L [3]) linked to human serum albumin. Previous studies have demonstrated that anti-CD40L antibodies can cause thromboembolic adverse events that arise through antibody Fc-mediated cross-linking between FcγRIIa and CD40L on platelets. The dazodalibep Fc negative fusion protein approach was initiated to mitigate these platelet-related safety issues.
Selectivity at ligand targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CD40 ligand Hs Fusion protein Binding 8.9 pIC50 - 1
pIC50 8.9 (IC50 1.4x10-9 M) [1]
Description: Measuring inhibition of CD40/CD40L interactions by enzyme-linked immunosorbent assay (ELISA)